Li Kang Biomedical Co (ROCO:6242) Cyclically Adjusted Book per Share: NT$23.02 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6242 Li Kang Biomedical Co Ltd ROCO:6242
81 GF Score
Price NT$34.00
GF Value NT$38.82
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Li Kang Biomedical Co Cyclically Adjusted Book per Share?

Li Kang Biomedical Co ROCO:6242 81 Cyclically Adjusted Book per Share is NT$23.02 as of Jun. 2026. GuruFocus rates ROCO:6242 with a GF Score™ of 81/100 and a GF Value™ of NT$38.82 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Li Kang Biomedical Co's adjusted book value per share for the three months ended in Jun. 2026 was NT$26.499. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.02 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Li Kang Biomedical Co's average Cyclically Adjusted Book Growth Rate was 9.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Li Kang Biomedical Co was 11.60% per year. The lowest was 8.40% per year. And the median was 10.25% per year.

As of today (2026-09-12), Li Kang Biomedical Co's current stock price is NT$34.00. Li Kang Biomedical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$23.02. Li Kang Biomedical Co's Cyclically Adjusted PB Ratio of today is 1.48.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Li Kang Biomedical Co was 4.15. The lowest was 1.48. And the median was 2.37.


Li Kang Biomedical Co  (ROCO:6242) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Li Kang Biomedical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=34.00/23.02
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Li Kang Biomedical Co was 4.15. The lowest was 1.48. And the median was 2.37.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Li Kang Biomedical Co Cyclically Adjusted Book per Share Related Terms


Li Kang Biomedical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Li Kang Biomedical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Li Kang Biomedical Co Cyclically Adjusted Book per Share Chart

Li Kang Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.67 15.66 17.53 19.79 21.74

Li Kang Biomedical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.97 21.45 21.74 22.49 23.02

ROCO:6242 vs BKNG, ABNB, RCL: Cyclically Adjusted Book per Share Comparison

For the Travel Services subindustry, Li Kang Biomedical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Li Kang Biomedical Co Cyclically Adjusted PB Ratio vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Li Kang Biomedical Co's Cyclically Adjusted PB Ratio falls into.


ROCO:6242
81GF Score
Li Kang Biomedical Co Ltd ROCO:6242
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Li Kang Biomedical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Li Kang Biomedical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=26.499/333.9520*333.9520
=26.499

Current CPI (Jun. 2026) = 333.9520.

Li Kang Biomedical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 11.445 241.428 15.831
201612 12.293 241.432 17.004
201703 12.819 243.801 17.559
201706 12.696 244.955 17.309
201709 14.987 246.819 20.278
201712 16.076 246.524 21.777
201803 16.785 249.554 22.462
201806 15.639 251.989 20.726
201809 16.100 252.439 21.299
201812 16.842 251.233 22.387
201903 17.471 254.202 22.952
201906 16.220 256.143 21.147
201909 16.622 256.759 21.619
201912 17.437 256.974 22.660
202003 17.594 258.115 22.763
202006 16.286 257.797 21.097
202009 17.201 260.280 22.070
202012 18.334 260.474 23.506
202103 18.741 264.877 23.628
202106 16.909 271.696 20.784
202109 17.092 274.310 20.808
202112 17.746 278.802 21.256
202203 18.315 287.504 21.274
202206 18.162 296.311 20.469
202209 19.438 296.808 21.871
202212 20.565 296.797 23.139
202303 21.476 301.836 23.761
202306 20.944 305.109 22.924
202309 21.721 307.789 23.567
202312 22.724 306.746 24.739
202403 27.330 312.332 29.222
202406 25.502 314.175 27.107
202409 26.088 315.301 27.631
202412 26.902 315.605 28.466
202503 27.357 319.799 28.568
202506 26.152 322.561 27.076
202509 26.523 324.800 27.270
202512 27.392 324.054 28.229
202603 27.713 330.213 28.027
202606 26.499 333.952 26.499

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$23.02 mean?
Li Kang Biomedical Co (ROCO:6242) has a Cyclically Adjusted Book per Share of NT$23.02 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Li Kang Biomedical Co and its competitors.
Is Li Kang Biomedical Co's Cyclically Adjusted Book per Share too high?
Li Kang Biomedical Co's current Cyclically Adjusted Book per Share is NT$23.02. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's Cyclically Adjusted Book per Share compare to BKNG and ABNB?
Li Kang Biomedical Co's Cyclically Adjusted Book per Share of NT$23.02 can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Travel & Leisure company?
A good Cyclically Adjusted Book per Share depends on the Travel & Leisure industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Li Kang Biomedical Co and its competitors. Li Kang Biomedical Co's current Cyclically Adjusted Book per Share is NT$23.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.82, compared to a current price of NT$34.00 — trading 12.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$23.02. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current Cyclically Adjusted Book per Share is NT$23.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?

Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued. The current stock price of NT$34.00 is trading 12.4% below its estimated GF Value™ of NT$38.82. GuruFocus considers Li Kang Biomedical Co to be Modestly Undervalued.

Key valuation signals for ROCO:6242:

  • Cyclically Adjusted Book per Share: NT$23.02
  • GF Value™: NT$38.82 vs. price of NT$34.00 (12.4% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Li Kang Biomedical Co Business Description

Address No.29, Huangong Road, Wangxingl, Yongkang District, Tainan City, TWN, 71041
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score

Get the complete analysis for ROCO:6242

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.00
Price
NT$38.82
GF Value